Directorio

What happens during the study? - You'll get the study medicine through an IV every 3 weeks - Doctors will take blood and urine samples - You'll have regular CT or MRI scans to check your health

This study lasts for 90 days. People who join will wear a cloth cap with special sensors on their head. A computer will help decide which group they are in. Some people will get a real treatment, and others will be in a control group, which means they do not get the real treatment. After each of the one, two, or three treatment sessions, people will answer ten questions about how they feel. A doctor or helper will also check how their brain and body are working for five minutes. One day after the treatment, they will get a brain scan and a test to see how blood moves in their brain. They will also have short check-ups in person on day one and day four, a phone call on day thirty, and another in-person visit on day ninety.

We are doing this study to find out is an experimental drug called RGX-314 can help improve or preserve vision. We will compare how this drug works to Eylea®, which is an approved therapy for age-related macular degeneration.

We are doing this study to understand how different factors, such as pain experiences and inflammation, may affect how acute back pain transitions to chronic back pain.

We are doing this study to find the most effective, safe dose of an experimental drug called iadademstat (the study drug). We want to know if the study drug is beneficial for people with R/R AML that have the FLT3 mutation when it is given in combination with gilteritinib.

You will get your own blood pressure monitor to use at home. We will teach you how to use it. You will check your blood pressure at home and share the numbers with your doctor's team for 12 months. The research team will also collect information in other ways, like: - Visits in person - Phone calls - Your medical records - Medicare data

We are doing this study to find out if an investigational implanted drug called Ocular Therapeutix Tyrosine Kinase Inhibitor Axitinib (the study drug) is a safe and effective option for people with nAMD.

This study needs two overnight stays to give a special medicine called choline and to make sure it is safe. It also includes ten visits to the clinic over about sixteen months.